Biodexa Pharmaceuticals PLC (BDRX)
3.62
-1.24
(-25.51%)
USD |
NASDAQ |
Nov 15, 16:00
3.65
+0.03
(+0.83%)
After-Hours: 20:00
Biodexa Pharmaceuticals Revenue (Annual): 0.4741M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.4741M |
| December 31, 2022 | 0.8656M |
| December 31, 2021 | 0.7952M |
| December 31, 2020 | 0.4402M |
| December 31, 2019 | 0.8606M |
| December 31, 2018 | 2.586M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.277M |
| December 31, 2016 | 1.792M |
| December 31, 2015 | 2.101M |
| December 31, 2014 | 0.2588M |
| December 31, 2013 | 0.23M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.4402M
Minimum
2020
0.8656M
Maximum
2022
0.6871M
Average
0.7952M
Median
2021
Revenue (Annual) Benchmarks
| Adaptimmune Therapeutics PLC | 60.28M |
| Verona Pharma PLC | -- |
| NuCana PLC | -- |
| Autolus Therapeutics PLC | 1.698M |
| TC BioPharm (Holdings) PLC | -- |